ENFERMEDADES HEPÁTICAS

Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hepatitis.

Malino, D, Codoni, G, Kirchner, T, Engel, B, Villamil, AM, Efe, C, Stättermayer, AF, Weltzsch, JP, Sebode, M, Bernsmeier, C, Lleo, A, Gevers, TJG, Kupcinskas, L, Castiella, A, Pinazo, J, De Martin, E, Bobis, I, Sandahl, TD, Pedica, F, Invernizzi, F, Del Poggio, P, Bruns, T, Kolev, M, Semmo, N, Bessone, F, Giguet, B, Poggi, G, Ueno, M, Jang, H, Elpek, GÖ, Soylu, NK, Cerny, A, Wedemeyer, H, Matter, MS, Uzun, S, Matilla-Cabello, G, Vergani, D, Mieli-Vergani, G, Lucena, MI, Andrade, RJ, Zen, YH, Taubert, R, Beretta-Piccoli, BT.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 38 (2026)

DOI: 10.1097/MEG.0000000000003142

MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.

Agirre-Lizaso, A, Huici-Izagirre, M, O'Rourke, CJ, Zhuravleva, E, Carpino, G, Overi, D, Urretabizkaia-Garmendia, J, Labiano, I, Korosec, A, Val, B, Calvisi, DF, Ilyas, SI, den Haan, JMM, Aspichueta, P, Hijona, E, La Casta, A, Jiménez-Agüero, R, Lleo, A, Macias, RIR, Gaudio, E, Andersen, JB, Schabbauer, G, Bujanda, L, Rodrigues, PM, Sharif, O, Banales, JM, Perugorria, MJ.

Signal Transduction and Targeted Therapy, 11 (2026)

DOI: 10.1038/s41392-026-02657-w

Existing challenges in the management of cholangiocarcinoma in Spain.

Martín, AJM, Lamarca, A, Banales, JM, Iglesias, M, Macarulla, T.

Clinical & Translational Oncology (2026)

DOI: 10.1007/s12094-026-04312-w

Review Article: Targeting Peroxisome Proliferator-Activated Receptors in Primary Biliary Cholangitis.

Schattenberg, JM, Banales, JM, Hirschfield, G, Trivedi, P, Cable, EE, McWherter, CA, Billin, AN, Crittenden, DB, Budas, G.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 63 (2026)

DOI: 10.1111/apt.70598

Epidemiology, clinical, molecular features, and prognosis of early-onset biliary tract cancer: A systematic review and meta-analysis..

Akkus E, Cammarota A, Izquierdo-Sanchez L, Banales JM, Forner A, Lleo A, Macias RIR, Lamarca A, Bouattour M.

JHEP REPORTS, 8 (2026)

DOI: 10.1016/j.jhepr.2025.101613

Cholangiocarcinoma 2026: status quo, unmet needs and priorities..

Banales JM, Rodrigues PM, Affò S, Andersen JB, Aspichueta P, Boulter L, Bridgewater J, Calvisi DF, Cardenas A, Cardinale V, Carpino G, Coulouarn C, Dopazo C, Edeline J, Fabris L, Folseraas T, Forner A, Goeppert B, Heikenwalder M, Kendall TJ, Khan SA, Klümpen HJ, Koerkamp BG, Lamarca A, Lindsey S, Lleo A, Luedde T, Macias RIR, Morement H, Nault JC, Olaizola P, Perugorria MJ, Raggi C, Rimassa L, Saborowski A, Valle JW, Vithayathil M, Vogel A, Braconi C.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 23 (2026)

DOI: 10.1038/s41575-025-01153-w

Blood Metabolomic Signature for Diagnosing Cirrhosis and Predicting Prognosis in Patients with Primary Sclerosing Cholangitis.

Catanzaro, E, Lapitz, A, Milkiewicz, P, Elgozair, M, Ahmed, F, Hov, JR, Folseraas, T, Carbone, M, Macias, RIR, Schramm, C, Alonso, C, Milkiewicz, M, Izquierdo-Sánchez, L, La Casta, A, Jimenez-Aguero, R, Perugorria, MJ, Cristoferi, L, Arrese, M, Chahuan, J, Bustamante, J, Dill, M, Rossi, S, Walmsley, M, Bujanda, L, Roberts, L, Karlsen, TH, Fabris, L, Cazzagon, N, Rodrigues, PM, Banales, JM.

DIGESTIVE AND LIVER DISEASE, 58 (2026)

DOI: 10.1016/j.dld.2026.01.128

Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses.

Han, Y, Byun, J, Vanlith, CJ, Cooley, MA, Shaw, VR, Hatia, RI, Ahmed, FY, Giama, NH, Ali, HM, Campbell, NA, Hassan, M, Andersen, JB, Ankoma-Sey, V, Banales, JM, Bujanda, L, Bathe, OF, Bekaii-Saab, TS, Borad, MJ, Björkström, NK, Chan, CHF, Cleary, SP, Cornillet, M, Folseraas, T, Galle, PR, Genkinger, JM, MacInnis, RJ, Gores, GJ, Goyal, L, Houlston, RS, Ilyas, SI, Javle, M, Johansen, JS, Christensen, TD, Kamath, AS, Kelley, RK, Khan, SA, Kim, RD, Kwee, SA, Lamarca, A, Lammert, F, Larusso, NF, Lindsey, S, Macias, RIR, Malhi, H, Patel, TC, Permuth, JB, Reeves, HL, Rossi, S, Sanchez, W, Smoot, RL, Swerdlow, AJ, Cao, HST, Valle, JW, Weinmann, A, Weinmann-Menke, J, Wong, LL, Zhang, XH, Zimmer, V, Zhu, AX, Lazaridis, KN, Juran, BD, Jalal, P, Knox, JJ, Hutchinson, A, Hicks, B, Koshiol, JE, Chanock, SJ, Hassan, MM, Amos, CI, McGlynn, KA, Roberts, LR.

HEPATOLOGY (2026)

DOI: 10.1097/HEP.0000000000001699

RePARylating biliary tumours to improve the efficacy of chemoimmunotherapy..

Rodrigues PM, Banales JM.

JOURNAL OF HEPATOLOGY, 84 (2026)

DOI: 10.1016/j.jhep.2025.10.028

miR-21-5p dysregulation is associated with gut microbiota dysbiosis and pro-oncogenic markers in primary sclerosing cholangitis with concomitant inflammatory bowel disease..

Santos AA, Pires D, Marques V, Alesina N, Rodrigues PM, Bravo AC, Gouveia C, Saraiva S, Correia L, Crespo R, da Silva JP, Cravo M, Banales JM, Torres J, Rodrigues CMP.

EXPERIMENTAL AND MOLECULAR PATHOLOGY, 145 (2026)

DOI: 10.1016/j.yexmp.2025.105013